⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TLX News
Telix Pharmaceuticals Limited American Depositary Shares
ROSEN, THE FIRST FILING FIRM, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX
globenewswire.com
TLX
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals
newsfilecorp.com
TLX
TLX LAWSUIT ALERT: Levi & Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors - Lead Plaintiff Deadline January 9, 2026
accessnewswire.com
TLX
Telix Pharmaceuticals Ltd. Shareholders with Large Losses Should Contact Robbins LLP for Information About the TLX Class Action
prnewswire.com
TLX
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
TLX
Pomerantz LLP Informs Investors of Securities Class Action Against Telix Pharmaceuticals Limited – TLX
accessnewswire.com
TLX
TLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Telix Pharmaceuticals Limited Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
TLX
Telix Pharmaceuticals (TLX) Faces Securities Class Action After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability - Hagens Berman
accessnewswire.com
TLX
TLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
globenewswire.com
TLX
January 9, 2026 Deadline: Join Class Action Lawsuit Against Telix Pharmaceuticals Ltd. (TLX) - Contact Levi & Korsinsky
accessnewswire.com
TLX